The invention and foundational development of CRISPR-Cas9 as a targeted gene-editing tool is credited to a collaborative scientific breakthrough pioneered primarily by Dr. Jennifer Doudna and Dr. Emmanuelle Charpentier, alongside independent and concurrent contributions by Dr. Feng Zhang and his research team at the Broad Institute. This monumental scientific achievement earned Doudna and Charpentier the Nobel Prize in Chemistry, sparking a global revolution in molecular biology and genetic medicine.